Test Price
2,800 AED✅ Home Collection Available
B4GALT1 Gene Glycosylation Disorder Type 2D (CDG-IId) Genetic Test in UAE | AED 2,800 | 2026 DHA Guidelines
تحليل B4GALT1 لاضطراب الغلكزة من النوع الثاني دي (CDG-IId) في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / الملخص التنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
دقة تشخيصية 99.9% مع خدمة سحب منزلي عالية الجودة، وإرشاد طبي بعد الفحص، وتحقق فوري من تغطية التأمين عبر واتساب.
Overview
The B4GALT1 gene test is a next‑generation sequencing analysis that detects pathogenic variants in the B4GALT1 gene, confirming or ruling out Congenital Disorder of Glycosylation Type IId (CDG-IId). This rare inherited metabolic condition affects protein glycosylation, and early molecular diagnosis guides specialist management and family planning.
تحليل جين B4GALT1 بتقنية التسلسل الجيني المتقدم يُشخّص اضطراب الغلكزة الخلقي النوع الثاني دي، وهو مرض استقلابي وراثي نادر، مما يساعد الأطباء في العلاج المبكر والتخطيط الأسري.
Clinical Indications & Specialist Collaboration
This test is requested by three core clinical specialties, each with a distinct diagnostic intent:
General Physician
Initial evaluation of unexplained developmental delay, hypotonia, or failure to thrive suspicious for an inborn error of metabolism.
Medical Geneticist
Confirmatory gene‑specific diagnosis, variant interpretation, and personalised management of CDG‑IId.
Genetic Counselor
Pre‑test pedigree construction, risk assessment for family members, and post‑test reproductive options discussion.
Our Test vs. Closest Alternative
| Feature | Our B4GALT1 NGS Test | Sanger Sequencing (Single‑Gene) |
|---|---|---|
| Method | Next‑Generation Sequencing (full gene coverage, CNV detection) | Targeted Sanger sequencing of exons only |
| Diagnostic yield | >99% sensitivity for single nucleotide and copy number variants | Up to 95% for point mutations, no CNV detection |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Sample Requirement | Blood, Extracted DNA, or one-drop blood on FTA Card | Blood or DNA only |
NGS technology also enables simultaneous reflex testing of related glycosylation disorder genes, if indicated.
2026 Regulatory Framework & Accreditation
- Federal Decree‑Law No. 41 of 2024 (Art. 87): All medical advertising and clinical services comply strictly with UAE healthcare advertising regulations, ensuring accurate, evidence‑based promotion.
- CDS Law 2026 (Minors): Genetic testing on individuals under 18 requires documented parental consent and mandatory pre‑ and post‑test genetic counselling, in full compliance with UAE child protection legislation.
- UAE PDPL: Patient genetic data is processed and stored exclusively within UAE borders under the Personal Data Protection Law, guaranteeing confidentiality and encryption.
- ISO 9001:2015 Certified: Laboratory and logistics processes are audited and certified (Cert: INT/EGQ/2509DA/3139), ensuring international quality management standards.
- DHA Facility License: 9834453 – a fully licensed healthcare facility under Dubai Health Authority.
Physician Insight & Safety Protocol
“This NGS test illuminates the molecular cause behind complex metabolic presentations, enabling precise prognosis and personalised care. As a clinician, I emphasize that DNA results must be correlated with biochemical and clinical findings before any intervention. Always discuss results with a certified geneticist or metabolic specialist to avoid misinterpretation.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
Medication Warning
Do not discontinue any prescribed medication without consulting your doctor. Genetic test results are not a substitute for emergency care or routine medical management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide valid informed consent; refusal to participate in mandatory genetic counselling; specimen collection from a patient in acute metabolic crisis (stabilization required first).
- Seek Emergency Care Immediately if: The patient develops persistent vomiting, lethargy, seizures, hypoglycaemia, or loss of consciousness. These require urgent hospital evaluation, not a scheduled genetic test.
- Pre‑test requirement: A clinical history and at least a three‑generation pedigree chart, preferably obtained during a genetic counselling session, must accompany the sample.
Frequently Asked Questions (English & العربية)
1. What does the B4GALT1 genetic test detect?
The B4GALT1 Genetic Test identifies B4GALT1 gene mutations linked to congenital disorder of glycosylation type IId. It scans the entire coding region for single nucleotide changes and deletions/duplications, confirming a diagnosis of CDG‑IId in symptomatic individuals and identifying asymptomatic carriers. يحدد تحليل الجين الطفرات المسؤولة عن الاضطراب الخلقي للغلكزة من النوع الثاني دي، ويؤكد التشخيص في الحالات المرضية أو يكتشف الحاملين غير المصابين.
2. How should I prepare for this DNA test?
No fasting or medication change is required; however, a genetic counselling session is mandatory before sample collection. A detailed three‑generation family history must be recorded. Our home collection team provides all sampling materials (FTA card, blood tubes) and ensures proper cold‑chain transport. لا حاجة للصيام أو تغيير الأدوية، لكن جلسة الاستشارة الوراثية قبل العينة إلزامية، كما يجب توثيق تاريخ العائلة لثلاثة أجيال.
3. Is this covered by UAE insurance?
Most UAE insurers cover genetic testing for CDG‑IId when a physician documents clinical necessity and pre‑authorisation is obtained. Our team verifies your policy and initiates direct billing before the appointment. Contact our insurance desk via WhatsApp at +971 54 548 8731 for immediate confirmation. معظم شركات التأمين في الإمارات تغطي الفحص عند وجود مبرر طبي؛ نتحقق من التغطية ونتولى الفوترة المباشرة بعد التواصل عبر واتساب.
Support & Home Collection | دعم وخدمة السحب المنزلي: +971 54 548 8731 | 8 AM – 11 PM daily
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians